Scafell Pike Challenge 2025
Join us for this fantastic opportunity to take a guided walk to the roof of England – Scafell Pike (978m).
Search
Search results
For Professionals
Are you supporting someone with inherited sight loss? We are here to help.
Snowdon Challenge 2025
Take on Snowdon for Retina UK and be rewarded with an epic view from the summit of Wales’ highest mountain.
Ben Nevis Challenge 2025
Take on Ben Nevis and be rewarded with the feeling that you have just hiked the UK’s highest mountain for Retina UK.
Welsh Three Peaks Challenge 2025
Support Retina UK and take on three of the highest, most iconic peaks in Wales within 24 hours, with The Welsh Three Peaks Challenge.
Webinar: Ask the expert with Simon Keightley
Our first Expert is Simon Keightley, a consultant ophthalmic surgeon and Director of Examinations for the International Council of Opthalmology. With more than 35 years in the field, Simon is ready and waiting for your questions.
Online information & support
Retina UK has a number of online support resources which we offer via social media.
From isolation to exploration
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
Light sensing small molecule given green light
Biotechnology company Kiora Pharmaceuticals has been given the go-ahead to start in-human testing of a novel “small molecule” treatment, known as KIO-301, for advanced vision loss in retinitis pigmentosa (RP). The phase 1b clinical trial will take place in Adelaide, Australia, and will begin enrolling participants towards the end of 2022.
FAQs: Luxturna (voretigene neparvovec)
Luxturna, a gene therapy, is only for the treatment of Leber congenital amaurosis type 2 (LCA2) and severe early-onset RP caused by mutations in a specific gene called RPE65.